Shenzhen TargetRx
Privately held: no public share price
Assets
(3 total)
3Total Assets
0Approved
1Phase 3 / Filed
2Phase 1–2 / Early
2Diseases
Quick filter:
| Target & Modality | |||
|---|---|---|---|
| Phase 3 | ALK;ROS1Small molecule | Non-Small Cell Lung Cancer | |
| Phase 1/2 | BCL-2Small molecule | Acute Myeloid Leukemia | |
| Phase 1 | Undisclosed / early pipelineSmall molecule | Non-Small Cell Lung Cancer |
Upcoming events
No upcoming trial completions or earnings dates on record for this company's assets.
Financial reports
No financial reports recorded.